94 related articles for article (PubMed ID: 24467242)
1. Design of inhibitors of ODCase.
Mundra S; Kotra LP
Future Med Chem; 2014 Feb; 6(2):165-77. PubMed ID: 24467242
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of orotidine-5'-monophosphate decarboxylase--discoveries and lessons.
Kotra LP; Pai EF
Nucleic Acids Symp Ser (Oxf); 2008; (52):85-6. PubMed ID: 18776265
[TBL] [Abstract][Full Text] [Related]
3. Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.
Purohit MK; Poduch E; Wei LW; Crandall IE; To T; Kain KC; Pai EF; Kotra LP
J Med Chem; 2012 Nov; 55(22):9988-97. PubMed ID: 22991951
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
Meza-Avina ME; Wei L; Buhendwa MG; Poduch E; Bello AM; Pai EF; Kotra LP
Mini Rev Med Chem; 2008 Mar; 8(3):239-47. PubMed ID: 18336344
[TBL] [Abstract][Full Text] [Related]
5. A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity.
Bello AM; Poduch E; Fujihashi M; Amani M; Li Y; Crandall I; Hui R; Lee PI; Kain KC; Pai EF; Kotra LP
J Med Chem; 2007 Mar; 50(5):915-21. PubMed ID: 17290979
[TBL] [Abstract][Full Text] [Related]
6. Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP
J Med Chem; 2006 Aug; 49(16):4937-45. PubMed ID: 16884305
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.
Bello AM; Poduch E; Liu Y; Wei L; Crandall I; Wang X; Dyanand C; Kain KC; Pai EF; Kotra LP
J Med Chem; 2008 Feb; 51(3):439-48. PubMed ID: 18189347
[TBL] [Abstract][Full Text] [Related]
9. Orotidine Monophosphate Decarboxylase--A Fascinating Workhorse Enzyme with Therapeutic Potential.
Fujihashi M; Mnpotra JS; Mishra RK; Pai EF; Kotra LP
J Genet Genomics; 2015 May; 42(5):221-34. PubMed ID: 26059770
[TBL] [Abstract][Full Text] [Related]
10. A proficient enzyme revisited: the predicted mechanism for orotidine monophosphate decarboxylase.
Lee JK; Houk KN
Science; 1997 May; 276(5314):942-5. PubMed ID: 9139656
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants for the inhibitory ligands of orotidine-5'-monophosphate decarboxylase.
Meza-Avina ME; Wei L; Liu Y; Poduch E; Bello AM; Mishra RK; Pai EF; Kotra LP
Bioorg Med Chem; 2010 Jun; 18(11):4032-41. PubMed ID: 20452222
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activities of 6-iodouridine and its prodrugs and potential for combination therapy.
Crandall IE; Wasilewski E; Bello AM; Mohmmed A; Malhotra P; Pai EF; Kain KC; Kotra LP
J Med Chem; 2013 Mar; 56(6):2348-58. PubMed ID: 23410043
[TBL] [Abstract][Full Text] [Related]
13. Drug target prioritization in Plasmodium falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach.
Yadav MK; Pandey SK; Swati D
J Bioinform Comput Biol; 2013 Aug; 11(4):1350003. PubMed ID: 23859267
[TBL] [Abstract][Full Text] [Related]
14. Theoretical studies of the effect of thio substitution on orotidine monophosphate decarboxylase substrates.
Phillips LM; Lee JK
J Org Chem; 2005 Feb; 70(4):1211-21. PubMed ID: 15704953
[TBL] [Abstract][Full Text] [Related]
15. The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase.
Takashima Y; Mizohata E; Krungkrai SR; Fukunishi Y; Kinoshita T; Sakata T; Matsumura H; Krungkrai J; Horii T; Inoue T
J Biochem; 2012 Aug; 152(2):133-8. PubMed ID: 22740703
[TBL] [Abstract][Full Text] [Related]
16. Substrate binding induces domain movements in orotidine 5'-monophosphate decarboxylase.
Harris P; Poulsen JC; Jensen KF; Larsen S
J Mol Biol; 2002 May; 318(4):1019-29. PubMed ID: 12054799
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the catalytic mechanism of a proficient enzyme: orotidine 5'-monophosphate decarboxylase.
Harris P; Navarro Poulsen JC; Jensen KF; Larsen S
Biochemistry; 2000 Apr; 39(15):4217-24. PubMed ID: 10757968
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of yeast orotidine 5'-monophosphate decarboxylase overexpressed from plasmid PGU2.
Bell JB; Jones ME
J Biol Chem; 1991 Jul; 266(19):12662-7. PubMed ID: 2061334
[TBL] [Abstract][Full Text] [Related]
19. A reexamination of the substrate utilization of 2-thioorotidine-5'-monophosphate by yeast orotidine-5'-monophosphate decarboxylase.
Smiley JA; Hay KM; Levison BS
Bioorg Chem; 2001 Apr; 29(2):96-106. PubMed ID: 11300698
[TBL] [Abstract][Full Text] [Related]
20. A proficient enzyme: insights on the mechanism of orotidine monophosphate decarboxylase from computer simulations.
Raugei S; Cascella M; Carloni P
J Am Chem Soc; 2004 Dec; 126(48):15730-7. PubMed ID: 15571395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
